The safety of ultrasound guided central venous cannulation in patients with liver disease

Shweta A Singh, Sandeep Sharma, Anshuman Singh, Anil K Singh, Utpal Sharma, Ajeet Singh Bhadoria, Shweta A Singh, Sandeep Sharma, Anshuman Singh, Anil K Singh, Utpal Sharma, Ajeet Singh Bhadoria

Abstract

Background: Central venous cannulation (CVC) is frequently required during the management of patients with liver disease with deranged conventional coagulation parameters (CCP). Since CVC is known to be associated with vascular complications, it is standard practice to transfuse Fresh-Frozen Plasma or platelets to correct CCP. These CCP may not reflect true coagulopathy in liver disease. Additionally CVC when performed under ultrasound guidance (USG-CVC) in itself reduces the incidence of complications.

Aim: To assess the safety of USG-CVC and to evaluate the incidence of complications among liver disease patients with coagulopathy.

Setting and design: An audit of all USG-CVCs was performed among adult patients with liver disease in a tertiary care center.

Materials and methods: Data was collected for all the adult patients (18-60 years) of either gender suffering from liver disease who had required USG-CVC. Univariate and multivariate regression analysis was done to identify possible risk factors for complications.

Results: The mean age of the patients was 42.1 ± 11.6 years. Mean international normalized ratio was 2.17 ± 1.16 whereas median platelet count was 149.5 (range, 12-683) × 10(9)/L. No major vascular or non-vascular complications were recorded in our patients. Overall incidence of minor vascular complications was 18.6%, of which 13% had significant ooze, 10.3% had hematoma formation and 4.7% had both hematoma and ooze. Arterial puncture and multiple attempts were independent risk factors for superficial hematoma formation whereas low platelet count and presence of ascites were independent risk factors for significant oozing.

Conclusion: Ultrasound guidance -CVC in liver disease patients with deranged coagulation is a safe and highly successful modality.

Keywords: Chronic liver disease; convention coagulation parameters; ultrasound guided central vein cannulation.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Receiver operating curves for international normalized ratio to predict hematoma formation and for platelet counts to predict oozing

References

    1. Doerfler ME, Kaufman B, Goldenberg AS. Central venous catheter placement in patients with disorders of hemostasis. Chest. 1996;110:185–8.
    1. Segal JB, Dzik WH. Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion. 2005;45:1413–25.
    1. Della Vigna P, Monfardini L, Bonomo G, Curigliano G, Agazzi A, Bellomi M, et al. Coagulation disorders in patients with cancer: Nontunneled central venous catheter placement with US guidance — A single-institution retrospective analysis. Radiology. 2009;253:249–52.
    1. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy — A prospective audit. Intensive Care Med. 1999;25:481–5.
    1. Foster PF, Moore LR, Sankary HN, Hart ME, Ashmann MK, Williams JW. Central venous catheterization in patients with coagulopathy. Arch Surg. 1992;127:273–5.
    1. Weigand K, Encke J, Meyer FJ, Hinkel UP, Munder M, Stremmel W, et al. Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters. Med Klin (Munich) 2009;104:331–5.
    1. Denys BG, Uretsky BF, Reddy PS. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation. 1993;87:1557–62.
    1. Sznajder JI, Zveibil FR, Bitterman H, Weiner P, Bursztein S. Central vein catheterization. Failure and complication rates by three percutaneous approaches. Arch Intern Med. 1986;146:259–61.
    1. Oguzkurt L, Tercan F, Kara G, Torun D, Kizilkilic O, Yildirim T. US-guided placement of temporary internal jugular vein catheters: Immediate technical success and complications in normal and high-risk patients. Eur J Radiol. 2005;55:125–9.
    1. Tercan F, Ozkan U, Oguzkurt L. US-guided placement of central vein catheters in patients with disorders of hemostasis. Eur J Radiol. 2008;65:253–6.
    1. Central venous catheters-ultrasound locating devices: Guidance, National Institute for Health and Clinical Excellence Website. Published 2002. [Updated 2005 and 2010 Dec 28; Last accessed on 2012 Oct 21]. Available from: .
    1. Rothschild JM. Rockville, MD: AHRQ Publications; 2001. [Last accessed on 2012 Oct 21]. Ultrasound guidance of central vein catheterization, on making health care safer: A critical analysis of patient safety practices; pp. 245–55. Available from: .
    1. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences. Blood. 2010;12(116):878–85.
    1. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147–56.
    1. Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71–87. viii.
    1. Keshava SN, Mammen T, Moses V. Transjugular liver biopsy: What to do and what not to do. Indian J Radiol Imaging. 2008;18:245–8.
    1. Stéphan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest. 1999;115:1363–70.
    1. Baron RM. Point: Should coagulopathy be repaired prior to central venous line insertion? Yes: Why take chances? Chest. 2012;141:1139–42.
    1. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208.
    1. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–36.
    1. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126:139–52.
    1. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41:553–8.
    1. Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anesth. 2001;48:1075–9.
    1. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–46.
    1. Wells AW, Llewelyn CA, Casbard A, Johnson AJ, Amin M, Ballard S, et al. The EASTR Study: Indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med. 2009;19:315–28.
    1. Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell’Era A, Fabris F, et al. Thrombin generation in patients with cirrhosis: The role of platelets. Hepatology. 2006;44:440–5.
    1. Dahlbäck B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol. 2004;79:109–16.
    1. Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? No. J Thromb Haemost. 2006;4:721–3.
    1. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth. 2000;12:319–23.
    1. Massicotte L, Beaulieu D, Thibeault L, Roy JD, Marleau D, Lapointe R, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation. 2008;85:956–62.
    1. Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: A dual phase study. Am J Gastroenterol. 2003;98:1391–4.
    1. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009;108:1083–91.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren